Regulation And Legal
Kobo Biotech FY25 Net Loss ₹52.3M Under CIRP
Kobo Biotech Ltd. submitted its FY 2024-25 Annual Report while under Corporate Insolvency Resolution Process (CIRP) initiated by NCLT in August 2024.
The company reported a net loss of ₹52.3 million f
